AAAAAA

   
Results: 1-8 |
Results: 8
SOLUTION STRUCTURE OF THE B-MYB DNA-BINDING DOMAIN - A POSSIBLE ROLE FOR CONFORMATIONAL INSTABILITY OF THE PROTEIN IN DNA-BINDING AND CONTROL OF GENE-EXPRESSION
Authors: MCINTOSH PB FRENKIEL TA WELLBORN U MCCORMICK JE KLEMPNAUER KH FEENEY J CARR MD
Citation: Pb. Mcintosh et al., SOLUTION STRUCTURE OF THE B-MYB DNA-BINDING DOMAIN - A POSSIBLE ROLE FOR CONFORMATIONAL INSTABILITY OF THE PROTEIN IN DNA-BINDING AND CONTROL OF GENE-EXPRESSION, Biochemistry, 37(27), 1998, pp. 9619-9629
PHARMACOKINETICS AND ANTITUMOR-ACTIVITY OF B.4152, A REACTIVE MOLECULAR COMBINATION OF 5-FLUOROURACIL AND N-(2-CHLOROETHYL)-N-NITROSOUREA, AND ITS URACIL ANALOG
Authors: LOADMAN PM MATTHEW AM MCCORMICK JE MCELHINNEY RS BIBBY MC
Citation: Pm. Loadman et al., PHARMACOKINETICS AND ANTITUMOR-ACTIVITY OF B.4152, A REACTIVE MOLECULAR COMBINATION OF 5-FLUOROURACIL AND N-(2-CHLOROETHYL)-N-NITROSOUREA, AND ITS URACIL ANALOG, Anti-cancer drug design, 11(2), 1996, pp. 117-128
NUCLEOSIDE ANALOGS .14. THE SYNTHESIS AND ANTITUMOR-ACTIVITY IN MICE OF MOLECULAR COMBINATIONS OF 5-FLUOROURACIL AND N-(2-CHLOROETHYL)-N-NITROSOUREA MOIETIES SEPARATED BY A 3-CARBON CHAIN
Authors: MCELHINNEY RS MCCORMICK JE BIBBY MC DOUBLE JA RADACIC M DUMONT P
Citation: Rs. Mcelhinney et al., NUCLEOSIDE ANALOGS .14. THE SYNTHESIS AND ANTITUMOR-ACTIVITY IN MICE OF MOLECULAR COMBINATIONS OF 5-FLUOROURACIL AND N-(2-CHLOROETHYL)-N-NITROSOUREA MOIETIES SEPARATED BY A 3-CARBON CHAIN, Journal of medicinal chemistry, 39(7), 1996, pp. 1403-1412
STRUCTURE OF THE B-MYB DNA-BINDING DOMAIN IN SOLUTION AND EVIDENCE FOR MULTIPLE CONFORMATIONS IN THE REGION OF REPEAT-2 INVOLVED IN DNA-BINDING - IMPLICATIONS FOR SEQUENCE-SPECIFIC DNA-BINDING BY MYB PROTEINS
Authors: CARR MD WOLLBORN U MCINTOSH PB FRENKIEL TA MCCORMICK JE BAUER CJ KLEMPNAUER KH FEENEY J
Citation: Md. Carr et al., STRUCTURE OF THE B-MYB DNA-BINDING DOMAIN IN SOLUTION AND EVIDENCE FOR MULTIPLE CONFORMATIONS IN THE REGION OF REPEAT-2 INVOLVED IN DNA-BINDING - IMPLICATIONS FOR SEQUENCE-SPECIFIC DNA-BINDING BY MYB PROTEINS, European journal of biochemistry, 235(3), 1996, pp. 721-735
F-19 NUCLEAR-MAGNETIC-RESONANCE CHEMICAL-SHIFTS OF FLUORINE-CONTAINING ALIPHATIC AMINO-ACIDS IN PROTEINS - STUDIES ON LACTOBACILLUS-CASEI DIHYDROFOLATE-REDUCTASE CONTAINING (2S,4S)-5-FLUOROLEUCINE
Authors: FEENEY J MCCORMICK JE BAUER CJ BIRDSALL B MOODY CM STARKMANN BA YOUNG DW FRANCIS P HAVLIN RH ARNOLD WD OLDFIELD E
Citation: J. Feeney et al., F-19 NUCLEAR-MAGNETIC-RESONANCE CHEMICAL-SHIFTS OF FLUORINE-CONTAINING ALIPHATIC AMINO-ACIDS IN PROTEINS - STUDIES ON LACTOBACILLUS-CASEI DIHYDROFOLATE-REDUCTASE CONTAINING (2S,4S)-5-FLUOROLEUCINE, Journal of the American Chemical Society, 118(36), 1996, pp. 8700-8706
PRODUCTION OF SOLUBLE ALPHA BETA-T-CELL RECEPTORS AS IMMUNOREGULATORYMOLECULES/
Authors: FAIRCHILD R BARBO J MCCORMICK JE MOORHEAD J
Citation: R. Fairchild et al., PRODUCTION OF SOLUBLE ALPHA BETA-T-CELL RECEPTORS AS IMMUNOREGULATORYMOLECULES/, Journal of cellular biochemistry, 1994, pp. 444-444
3D C-13 H-1 NMR-BASED ASSIGNMENTS FOR SIDE-CHAIN RESONANCES OF LACTOBACILLUS-CASEI DIHYDROFOLATE-REDUCTASE - EVIDENCE FOR SIMILARITIES BETWEEN THE SOLUTION AND CRYSTAL-STRUCTURES OF THE ENZYME
Authors: SOTERIOU A CARR MD FRENKIEL TA MCCORMICK JE BAUER CJ SALI D BIRDSALL B FEENEY J
Citation: A. Soteriou et al., 3D C-13 H-1 NMR-BASED ASSIGNMENTS FOR SIDE-CHAIN RESONANCES OF LACTOBACILLUS-CASEI DIHYDROFOLATE-REDUCTASE - EVIDENCE FOR SIMILARITIES BETWEEN THE SOLUTION AND CRYSTAL-STRUCTURES OF THE ENZYME, Journal of biomolecular NMR, 3(5), 1993, pp. 535-546
NUCLEOSIDE ANALOGS .13. THE EFFECT ON ANTITUMOR-ACTIVITY OF VARYING THE URACIL 5-SUBSTITUENT AND THE POINT OF ATTACHMENT (N(1) OR N(3)) OF THE URACIL MOIETY IN SECONUCLEOSIDE NITROSOUREAS
Authors: BIBBY MC DOUBLE JA MCCORMICK JE MCELHINNEY RS RADACIC M PRATESI G DUMONT P
Citation: Mc. Bibby et al., NUCLEOSIDE ANALOGS .13. THE EFFECT ON ANTITUMOR-ACTIVITY OF VARYING THE URACIL 5-SUBSTITUENT AND THE POINT OF ATTACHMENT (N(1) OR N(3)) OF THE URACIL MOIETY IN SECONUCLEOSIDE NITROSOUREAS, Anti-cancer drug design, 8(2), 1993, pp. 115-128
Risultati: 1-8 |